FDA Pharmacal eczema cream recall
Definition
A nationwide voluntary recall announced by the U.S. Food and Drug Administration (FDA) on May 8, 2026, initiated by Pharmacal Research Laboratories, Inc., for one lot (1024088) of MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream (6oz tube) due to contamination with Staphylococcus aureus bacteria.
A consumer safety alert highlighting potential health risks from microbial contamination in an over-the-counter eczema treatment product distributed nationwide through wholesalers, retailers like HE Butt Grocery, and online platforms such as Amazon.
An event underscoring the importance of checking lot numbers on skincare products, as the affected cream could lead to infections ranging from skin irritations to life-threatening conditions like sepsis, especially for those with compromised immune systems.
Examples
The FDA Pharmacal eczema cream recall hit just as I was slathering it on—talk about timing as impeccable as a skunk's perfume.
After the FDA Pharmacal eczema cream recall, my medicine cabinet underwent a purge rivaling Marie Kondo's wildest dreams.
Grandpa shrugged off the FDA Pharmacal eczema cream recall, claiming his skin was tougher than the bacteria—spoiler: it's not.
In the era of the FDA Pharmacal eczema cream recall, we're all amateur lot-number detectives with lotions.